In 1984, Jacobus Rentmeester, then a student at the University of North Carolina, took a photograph of Michael Jordan for Time Magazine, which made it appear that Jordan was about to dunk the ball with one hand. Although such photographs are quite common, Rentmeester's photo was unique in several ways. For one thing, Jordan's in-the-air pose resembled a leap in ballet.
New Jersey copyright owners may be interested in a recent decision made by the U.S. Supreme Court. The decision will affect when work needs to be registered with the United States Copyright Office if the filer wants to enforce their rights as an owner. A copyright owner has to have their work registered with this office if they want to file litigation. This underscores the importance of filing copyright applications as soon as possible.
When a composer creates a piece of music, intellectual property laws protect their ability to control when and where their work is performed. This means that a composer has the right to decide if their music can be played, whether the venue is a large stadium in New Jersey or a small concert in New Orleans. This legal standard helps maintain the integrity of creative work.
Alfonso Ribiero, known for his signature "Carlton" dance performed by his character on "The Fresh Prince of Bel-Air," filed suit against Epic Games, owner of the Fortnite video game. Epic featured Ribiero's distinct dance moves as an add-on dance players may purchase for their Fortnite characters.
New Jersey fans of Ariana Grande may be interested to learn that the pop superstar is being sued for copyright infringement. A painter based in Las Vegas, Nev., claims that the singer used some of his work in her music video for "God Is a Woman" without his permission. The image, which shows a woman as a candle wick in the sky, was only altered slightly from the original painting, according to the federal lawsuit. The painter said he only learned about the music video after reading about it online.
New Jersey residents face a number of advertisements when they scroll the internet or even use their mobile phones. Two of the companies involved in creating the technology targeting ads to viewers' interests have been engaged in an intellectual property dispute over their software. Free Stream Media, otherwise known as Samba, patented a system that allows the company to send advertisements to mobile phones based on the owners' television viewing options. The company can charge advertisers for its ability to target advertisements based on customers' viewing choices.
YouTube has become home to many content creators in New Jersey and across the country who have released videos and amassed millions of fans. Still, some YouTubers have expressed concerns about how the platform addresses copyright complaints. One creator, known as TheFatRat, said that he has experienced frequent problems after other people and companies have tried to remove his original work after they attempted to claim it as their own. This means that the remaining video owners could receive thousands of dollars in advertising revenue as a result of fraudulent copyright claims.
The information age has created a raft of new challenges for copyright holders and content creators in New Jersey and around the country. Digital infringers often defend their actions by claiming that their use of copyrighted materials was permitted under the fair use doctrine or was exempted from copyright law because the original work was substantially transformed. These issues were recently argued in a case filed by a photographer against a New York media company.
For decades, boys and girls in New Jersey have participated in programs operated by the Boy Scouts and Girl Scouts. The Boy Scouts of America's decision in 2017 to include girls has prompted the Girl Scouts of the United States of America to file a lawsuit alleging that BSA has confused consumers and infringed on trademarks held by the GSUSA.
In the pharmaceutical industry, patents can be the key to financial success. Multiple sclerosis patients in New Jersey and across the country have made Teva Pharmaceuticals' Copaxone a high-earning drug. The treatment for relapsing MS had brand-only sales of $527 for the 20 mg/mL dose from August 2017 to August 2018; the 40 mg/mL dose brought in $2.86 billion in sales for the Israeli company in the same period of time. While multiple generics have been introduced into the market to compete with Teva's 20 mg/mL original, the company has kept competitors out of the market with dosing patents on the higher-volume injection.